Drug companies are betting AI can fix the slow, expensive process of testing new drugs in humans.
The Digital Medicine department at the University of Bern among other universities are increasingly using AI to analyse patient tissue samples.
Keystone / Gaetan Bally
AI has transformed the search for new medicines. Now drug companies are betting it can fix the slow, expensive process of testing them in humans.
Generated with artificial intelligence.
This content was published on
AI is helping life sciences leaders rethink clinical trials by improving dose decisions, patient-level insight, and capital…
Merck cut a drug discovery cycle by 33% and ships compliant marketing 80% faster. Mastercard is rethinking fraud disputes. Both…
The goal is to ensure that as AI accelerates the machine of drug development, we have deliberate mechanisms for human…
In this week’s edition of InnovationRx, we look at the opportunities and challenges of using AI to personalize healthcare and…
Eli Lilly and J&J recently announced partnerships with AI chipmaker Nvidia, pointing to a broader trend of tie-ups to advance…
New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed…
Chinese team uses supercomputer to cut drug screening time from years to seconds
